CellWell record HH-568532
Application of Low-Dose Radiotherapy Combined with Immunotherapy for Drug-Resistant Hepatic Metastasis: a Case Series Analysis
Gege Liang; Bo Lyu; Cuicui Geng; Yiru Han; Yang Guo; Lu Zhang; Lizhe Sun
2027
In plain language
In six retrospective patients with refractory diffuse liver metastases, low-dose whole-liver radiotherapy plus PD-1 immunotherapy was associated with a 66.7% objective response rate and no definitively attributable grade 3 or higher toxicity.
- Evidence
- Emerging
- Design
- Case report
Cite this record: https://thecellwell.org/studies/HH-568532
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.